Successful dual therapy of aztreonam and ceftazidime-avibactam for multidrug-resistant Stenotrophomonas maltophilia infection in a preterm neonate: A life-saving approach
Abstract
Stenotrophomonas maltophilia is a multidrug-resistant gram-negative pathogen associated with high morbidity and mortality, especially in immunocompromised patients. Its resistance mechanisms include aminoglycoside-modifying enzymes, qnrB-like quinolone resistance genes, multidrug efflux pumps, and β-lactamases (L1 and L2). With the increasing incidence of S. maltophilia infections, effective treatment strategies are urgently needed to combat its growing resistance. We present the case of a preterm male neonate, born at 30 weeks of gestation, who developed respiratory distress requiring mechanical ventilation. Empiric antibiotics were initiated but failed to prevent clinical deterioration. Respiratory cultures confirmed that multidrug-resistant S. maltophilia is resistant to standard therapies, necessitating a novel dual regimen of ceftazidime-avibactam and aztreonam. This combination therapy was administered for 14 days, leading to microbiological clearance and clinical improvement, allowing successful extubation. To the best of our knowledge, this is the first documented case of ceftazidime-avibactam and aztreonam successfully treating multidrug-resistant S. maltophilia infection in a preterm infant. This case underscores the potential of ceftazidime-avibactam and aztreonam as a viable therapeutic option for multidrug-resistant S. maltophilia infections in neonates. Further studies are warranted to validate its safety and efficacy in similar cases.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.